DCMQA, a caffeoylquinic acid derivative alleviates NMDA-induced neurotoxicity via modulating GluN2A and GluN2B-containing NMDA receptors in vitro - Yang, Y; Gao, H; Liu, W; Jiang, X; Shen, Z; Li, X; Ren, T; Xu, Z; Cheng, G; Zhao, Q (Toxicol In Vitro, 2020)